Automate Your Wheel Strategy on TCRT
With Tiblio's Option Bot, you can configure your own wheel strategy including TCRT - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol TCRT
- Rev/Share 0.0062
- Book/Share 0.6607
- PB 5.1155
- Debt/Equity 0.0
- CurrentRatio 1.0047
- ROIC -3.9747
- MktCap 6686485.0
- FreeCF/Share 16.1449
- PFCF 0.2586
- PE -1.3295
- Debt/Assets 0.0
- DivYield 0
- ROE -1.6934
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 3
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Alaunos Therapeutics Announces $2.0 Million Registered Direct Offering
Published: June 23, 2025 by: GlobeNewsWire
Sentiment: Neutral
HOUSTON, June 23, 2025 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (Nasdaq: TCRT) (the “Company”) today announced that it has entered into a definitive agreement with certain investors (the “SPA”) for the purchase and sale of an aggregate of 610,399 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $3.36 per share (or pre-funded warrant in lieu thereof) in a registered direct offering (the “Offering”) on June 20, 2025 based on the 5-day average Nasdaq official closing price. The aggregate gross proceeds to the Company of this offering are expected to be approximately $2.0 million, …
Read More
About Alaunos Therapeutics, Inc. (TCRT)
- IPO Date 2005-08-24
- Website https://www.alaunos.com
- Industry Biotechnology
- CEO Dale Curtis Hogue Jr.
- Employees 1